Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Sousa

Showing results (21-30 of 132) with videos related to

Pageof 14
Sort By:
Revista Espanola De Enfermedades Digestivas|June 4, 2024
Autoimmune hepatitis after COVID-19 infectionAlberto Pérez Ramírez, Ignacio López Bueno, José Manuel Sousa Martín
Current Drug Delivery|July 27, 2013
Influence of drug incorporation, temperature and storage time on the pH, textural and rheological properties of different poloxamer hydrogelsHugo Almeida, Maria Helena Amaral, Paulo Lobão, et al.
Colloids and Surfaces. B, Biointerfaces|January 17, 2015
Nanotechnological carriers for cancer chemotherapy: the state of the artMarilene Estanqueiro, Maria Helena Amaral, Jaime Conceição, et al.
World Journal of Gastroenterology|August 10, 2018
Rethinking <i>de novo</i> immune hepatitis, an old concept for liver allograft rejection: Relevance of glutathione S-transferase T1 mismatchIsabel Aguilera, Elena Aguado-Dominguez, Jose Manuel Sousa, et al.
Expert Opinion on Drug Delivery|May 22, 2013
Applications of poloxamers in ophthalmic pharmaceutical formulations: an overviewHugo Almeida, Maria Helena Amaral, Paulo Lobão, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|October 31, 2012
Pluronic® F-127 and Pluronic Lecithin Organogel (PLO): main features and their applications in topical and transdermal administration of drugsHugo Almeida, Maria Helena Amaral, Paulo Lobão, et al.
Drug Discovery Today|October 15, 2013
In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulationsHugo Almeida, Maria Helena Amaral, Paulo Lobão, et al.
International Journal of Nanomedicine|July 8, 2021
Improving Drug Delivery for Alzheimer's Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ HydrogelsSara Cunha, Ben Forbes, José Manuel Sousa Lobo, et al.
Medicina Clinica|February 5, 2025
Hepatic phenomena associated with SARS-CoV-2: Acute liver injury, autoimmune hepatitis and post-vaccinationRoberto Pertusa Mataix, José Salvador García Morillo, José Manuel Sousa Martín
BMJ Case Reports|June 21, 2011
Congenital laryngomucocoele: a rare cause for CHAOSManuel Sousa Cunha, Patrícia Janeiro, Rosário Fernandes, et al.
Pageof 14

Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
Revista Espanola De Enfermedades Digestivas|June 4, 2024
Autoimmune hepatitis after COVID-19 infectionAlberto Pérez Ramírez, Ignacio López Bueno, José Manuel Sousa Martín
Current Drug Delivery|July 27, 2013
Influence of drug incorporation, temperature and storage time on the pH, textural and rheological properties of different poloxamer hydrogelsHugo Almeida, Maria Helena Amaral, Paulo Lobão, et al.
Colloids and Surfaces. B, Biointerfaces|January 17, 2015
Nanotechnological carriers for cancer chemotherapy: the state of the artMarilene Estanqueiro, Maria Helena Amaral, Jaime Conceição, et al.
World Journal of Gastroenterology|August 10, 2018
Rethinking <i>de novo</i> immune hepatitis, an old concept for liver allograft rejection: Relevance of glutathione S-transferase T1 mismatchIsabel Aguilera, Elena Aguado-Dominguez, Jose Manuel Sousa, et al.
Expert Opinion on Drug Delivery|May 22, 2013
Applications of poloxamers in ophthalmic pharmaceutical formulations: an overviewHugo Almeida, Maria Helena Amaral, Paulo Lobão, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|October 31, 2012
Pluronic® F-127 and Pluronic Lecithin Organogel (PLO): main features and their applications in topical and transdermal administration of drugsHugo Almeida, Maria Helena Amaral, Paulo Lobão, et al.
Drug Discovery Today|October 15, 2013
In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulationsHugo Almeida, Maria Helena Amaral, Paulo Lobão, et al.
International Journal of Nanomedicine|July 8, 2021
Improving Drug Delivery for Alzheimer's Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ HydrogelsSara Cunha, Ben Forbes, José Manuel Sousa Lobo, et al.
Medicina Clinica|February 5, 2025
Hepatic phenomena associated with SARS-CoV-2: Acute liver injury, autoimmune hepatitis and post-vaccinationRoberto Pertusa Mataix, José Salvador García Morillo, José Manuel Sousa Martín
BMJ Case Reports|June 21, 2011
Congenital laryngomucocoele: a rare cause for CHAOSManuel Sousa Cunha, Patrícia Janeiro, Rosário Fernandes, et al.
Pageof 14